Related references
Note: Only part of the references are listed.Obesity and cancer pathogenesis
Nathan A. Berger
YEAR IN DIABETES AND OBESITY (2014)
Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From a Herceptin Adjuvant Trial
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L. C. Collins et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
D. H. Morrison et al.
BRITISH JOURNAL OF CANCER (2012)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?
Benjamin D. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic Significance of Young Age (<35 Years) by Subtype Based on ER, PR, and HER2 Status in Breast Cancer: A Nationwide Registry-Based Study
Eun-Kyu Kim et al.
WORLD JOURNAL OF SURGERY (2011)
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer
G. Cancello et al.
ANNALS OF ONCOLOGY (2010)
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term survival expectations of cancer patients in Europe in 2000-2002
Hermann Brenner et al.
EUROPEAN JOURNAL OF CANCER (2009)
Survival trends in European cancer patients diagnosed from 1988 to 1999
Arduino Verdecchia et al.
EUROPEAN JOURNAL OF CANCER (2009)
Patient and Tumor Characteristics Associated With Increased Mortality in Young Women (≤40 Years) With Breast Cancer
Ankit Bharat et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Breast Cancer Before Age 40 Years
Carey K. Anders et al.
SEMINARS IN ONCOLOGY (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea - A report from the Korean Breast Cancer Society
Sei Hyun Ahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer
Janice M. Walshe et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease
M. Colleoni et al.
ANNALS OF ONCOLOGY (2006)
Effects of young age at presentation on survival in breast cancer
Nagi S. El Saghir et al.
BMC CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Benefit of taxanes as adjuvant chemotherapy for early breast cancer - Pooled analysis of 15,500 patients
Emilio Bria et al.
CANCER (2006)
Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study
JA Petrek et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study - NCICCTG MA.5
WR Parulekar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
S Aebi et al.
LANCET (2000)
Share Paper
